BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 33669537)

  • 1. Tumor Immune Evasion Induced by Dysregulation of Erythroid Progenitor Cells Development.
    Grzywa TM; Justyniarska M; Nowis D; Golab J
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of erythrocytes and erythroid progenitor cells in tumors.
    Zhang H; Wan GZ; Wang YY; Chen W; Guan JZ
    Open Life Sci; 2022; 17(1):1641-1656. PubMed ID: 36567722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells.
    Zhao L; He R; Long H; Guo B; Jia Q; Qin D; Liu SQ; Wang Z; Xiang T; Zhang J; Tan Y; Huang J; Chen J; Wang F; Xiao M; Gao J; Yang X; Zeng H; Wang X; Hu C; Alexander PB; Symonds ALJ; Yu J; Wan Y; Li QJ; Ye L; Zhu B
    Nat Med; 2018 Oct; 24(10):1536-1544. PubMed ID: 30297899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding and targeting erythroid progenitor cells for effective cancer therapy.
    Wang Q; Poole RA; Opyrchal M
    Curr Opin Hematol; 2023 Jul; 30(4):137-143. PubMed ID: 37052294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CD71
    Grzywa TM; Nowis D; Golab J
    Pharmacol Ther; 2021 Dec; 228():107927. PubMed ID: 34171326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythroid-transdifferentiated myeloid cells promote portal vein tumor thrombus in hepatocellular carcinoma.
    Zhu WH; Chen J; Huang RK; Zhang Y; Huang ZX; Pang XQ; Hu B; Yang Y; Li X
    Theranostics; 2023; 13(13):4316-4332. PubMed ID: 37649603
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor-associated CD8
    Fan X; Peng H; Wang X; Sun Y; Dong Y; Zhou J; Chen J; Huang S
    Front Immunol; 2024; 15():1381919. PubMed ID: 38799424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LAG3
    Pang XQ; Li X; Zhu WH; Huang RK; Mo ZS; Huang ZX; Zhang Y; Xie DY; Gao ZL
    Antiviral Res; 2023 May; 213():105592. PubMed ID: 37004734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dangguibuxue decoction abolishes abnormal accumulation of erythroid progenitor cells induced by melanoma.
    Li C; Zhu F; Xu C; Xiao P; Wen J; Zhang X; Wu B
    J Ethnopharmacol; 2019 Oct; 242():112035. PubMed ID: 31226383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extramedullary hematopoiesis contributes to enhanced erythropoiesis during pregnancy via TGF-β signaling.
    Fu Y; Li Z; Lin W; Yao J; Jiang X; Shu Q; Mao X; Tu J; Liang X; Li L
    Front Immunol; 2023; 14():1295717. PubMed ID: 38045690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD71
    Bozorgmehr N; Okoye I; Mashhouri S; Lu J; Koleva P; Walker J; Elahi S
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37236637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy.
    Long H; Jia Q; Wang L; Fang W; Wang Z; Jiang T; Zhou F; Jin Z; Huang J; Zhou L; Hu C; Wang X; Zhang J; Ba Y; Gong Y; Zeng X; Zeng D; Su X; Alexander PB; Wang L; Wang L; Wan YY; Wang XF; Zhang L; Li QJ; Zhu B
    Cancer Cell; 2022 Jun; 40(6):674-693.e7. PubMed ID: 35594863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TNF/TNFR2 signaling pathway is a key regulatory factor in endothelial progenitor cell immunosuppressive effect.
    Naserian S; Abdelgawad ME; Afshar Bakshloo M; Ha G; Arouche N; Cohen JL; Salomon BL; Uzan G
    Cell Commun Signal; 2020 Jun; 18(1):94. PubMed ID: 32546175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD71+VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-β.
    Shahbaz S; Bozorgmehr N; Koleva P; Namdar A; Jovel J; Fava RA; Elahi S
    PLoS Biol; 2018 Dec; 16(12):e2006649. PubMed ID: 30550561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proportion and role of CD45+ erythroid progenitor cells in patients with tongue cancer metastasis].
    Wang MQ; Hou M; Lin DP; Wang YG
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Jul; 54(7):445-449. PubMed ID: 31288323
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging role of natural products in cancer immunotherapy.
    Dong S; Guo X; Han F; He Z; Wang Y
    Acta Pharm Sin B; 2022 Mar; 12(3):1163-1185. PubMed ID: 35530162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral CD45
    Chen J; Qiao YD; Li X; Xu JL; Ye QJ; Jiang N; Zhang H; Wu XY
    Cancer Lett; 2021 Feb; 499():85-98. PubMed ID: 33279623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis.
    Suragani RN; Cadena SM; Cawley SM; Sako D; Mitchell D; Li R; Davies MV; Alexander MJ; Devine M; Loveday KS; Underwood KW; Grinberg AV; Quisel JD; Chopra R; Pearsall RS; Seehra J; Kumar R
    Nat Med; 2014 Apr; 20(4):408-14. PubMed ID: 24658078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway.
    Li X; Wang S; Mu W; Barry J; Han A; Carpenter RL; Jiang BH; Peiper SC; Mahoney MG; Aplin AE; Ren H; He J
    J Exp Clin Cancer Res; 2022 Jan; 41(1):41. PubMed ID: 35086548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy.
    Draghiciu O; Lubbers J; Nijman HW; Daemen T
    Oncoimmunology; 2015 Jan; 4(1):e954829. PubMed ID: 25949858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.